title: Reply to M.C. Chamberlain.
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX mrgilbert@mdanderson.org.
authors.forename: Mark R
authors.initials: MR
authors.lastname: Gilbert
authors.affiliation: Radiation Therapy Oncology Group Statistical Center, Philadelphia, PA.
authors.forename: James
authors.initials: J
authors.lastname: Dignam
authors.affiliation: Radiation Therapy Oncology Group Statistical Center, Philadelphia, PA.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Pugh
authors.affiliation: The University of Texas MD Anderson Cancer Center; The University of Texas Health Science Center-School of Nursing, Houston, TX.
authors.forename: Terri S
authors.initials: TS
authors.lastname: Armstrong
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Wefel
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Ken
authors.initials: K
authors.lastname: Aldape
authors.affiliation: University Hospital Zurich, Zurich, Switzerland.
authors.forename: Roger
authors.initials: R
authors.lastname: Stupp
authors.affiliation: Lausanne University Hospitals, Lausanne, Switzerland.
authors.forename: Monika
authors.initials: M
authors.lastname: Hegi
authors.affiliation: Radiation Therapy Oncology Group Statistical Center, Philadelphia, PA.
authors.forename: Minhee
authors.initials: M
authors.lastname: Won
authors.affiliation: Emory University Winship Cancer Center, Atlanta, GA.
authors.forename: Walter J
authors.initials: WJ
authors.lastname: Curran
authors.affiliation: University of Maryland, Baltimore, MD.
authors.forename: Minesh P
authors.initials: MP
authors.lastname: Mehta
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage*; D001932:Brain Neoplasms / Q000188:drug therapy*; D003606:Dacarbazine / Q000031:analogs & derivatives*; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy*; D006801:Humans; D008297:Male
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine
references.citation: Cancer. 2008 Oct 15;113(8):2152-7
references.pmid: 18756530
references.citation: J Neurooncol. 2008 Sep;89(2):179-85
references.pmid: 18431544
references.citation: Lancet Oncol. 2012 Jul;13(7):707-15
references.pmid: 22578793
references.citation: J Clin Oncol. 2007 Aug 1;25(22):3357-61
references.pmid: 17664483
references.citation: J Clin Oncol. 2013 Nov 10;31(32):4085-91
references.pmid: 24101040
references.citation: N Engl J Med. 2005 Mar 10;352(10):987-96
references.pmid: 15758009
references.citation: Br J Cancer. 1992 Feb;65(2):287-91
references.pmid: 1739631
references.citation: J Clin Oncol. 2013 Nov 10;31(32):4076-84
references.pmid: 24101048
references.citation: Lancet Oncol. 2012 Sep;13(9):916-26
references.pmid: 22877848
references.citation: N Engl J Med. 2005 Mar 10;352(10):997-1003
references.pmid: 15758010
references.citation: J Clin Oncol. 2014 May 20;32(15):1633-4
references.pmid: 24752051